1. Home
  2. PLSE vs IRMD Comparison

PLSE vs IRMD Comparison

Compare PLSE & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$25.48

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo iRadimed Corporation

IRMD

iRadimed Corporation

HOLD

Current Price

$92.86

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLSE
IRMD
Founded
2014
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
PLSE
IRMD
Price
$25.48
$92.86
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$22.00
$116.00
AVG Volume (30 Days)
338.8K
97.5K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
0.95%
EPS Growth
N/A
16.67
EPS
N/A
0.45
Revenue
N/A
$83,814,000.00
Revenue This Year
$840.00
$12.38
Revenue Next Year
$287.54
$11.31
P/E Ratio
N/A
$199.32
Revenue Growth
N/A
14.43
52 Week Low
$12.56
$50.88
52 Week High
$27.98
$107.90

Technical Indicators

Market Signals
Indicator
PLSE
IRMD
Relative Strength Index (RSI) 59.22 61.17
Support Level $17.58 $92.51
Resistance Level $27.14 $98.31
Average True Range (ATR) 1.84 2.78
MACD 0.49 1.12
Stochastic Oscillator 73.39 94.94

Price Performance

Historical Comparison
PLSE
IRMD

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About IRMD iRadimed Corporation

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

Share on Social Networks: